{
    "Trade/Device Name(s)": [
        "WowGoHealth Blood Glucose Monitoring System",
        "WowGoHealth Blood Glucose Monitor",
        "WowGoHealth Blood Glucose Test Strip"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K171785",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141351"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "August 16, 2017",
    "Summary Letter Received Date": "August 18, 2017",
    "Submission Date": "September 13, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood (fingertip or forearm)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "WowGoHealth Blood Glucose Meter (Model GSH-BGM902)"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "FAD-glucose dehydrogenase enzymatic reaction",
        "Bluetooth mediated data transmission"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "In vitro diagnostic testing"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Lancing device",
        "Lancet",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for WowGoHealth Blood Glucose Monitoring System, a home-use, Bluetooth-enabled blood glucose monitoring device for self-testing in diabetics",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the fingertips or forearm; for self-testing by people with diabetes at home to monitor effectiveness of a diabetes control program; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}